Non-steroidal anti-inflammatory therapy for asthma
Identifieur interne : 002743 ( Main/Exploration ); précédent : 002742; suivant : 002744Non-steroidal anti-inflammatory therapy for asthma
Auteurs : Ab Kay [Royaume-Uni] ; Nc Barnes [Royaume-Uni]Source :
- The Lancet [ 0140-6736 ] ; 1998.
English descriptors
- Teeft :
- Allergy, Analgesic, Antiinflammatory, Antiinflammatory effects, Antiinflammatory therapy, Arthur banner, Asthma, Asthmatic, Asthmatic patients, Banner states, Banner1, Beneficial effect, Brompton, Bronchial asthma, Capell, Capell centre, Chronic asthma, Clinical immunology, Correspondence commentary correspondence therapy, Corticosteroid, Crit, Crossover, Crossover study, Crossover trial, Current medication, Cyclosporin, Difficult asthmatics, Disease exacerbations, Diseasemodifying, Dmards, Doubleblind, February, Further multicentre studies, Gammaglobulin, Gunneberg, Hydroxychloroquine, Immunoglobulin, Immunoglobulin treatment, Immunology, Imperial college school, Important option, Important placebo effect, Individual patient, Intravenous, Intravenous immunoglobulin, Lancet, London chest hospital, Lung function, Lung institute, Madhok, Methotrexate, Methotrexate spares, Methotrexate trials, Multicentre, National heart, Nonsteroidal, Nonsteroidal drugs, Nsaid, Open studies, Oral corticosteroid doses, Oral corticosteroid therapy, Particular interest, Pathway, Pediatrics, Pharmacol, Placebo, Potential benefit, Prednisolone, Prednisolone dose, Prostaglandin, Prostaglandin synthesis, Pulm, Pulm pharmacol, Referenced, Referenced doubleblind, Respir, Respir crit care, Rheumatic diseases, Rheumatologist, Royal brompton hospital, Royal infirmary, Saards, Several trials, Severe asthma, Severe asthmatics, Steroid, Steroid reduction, Steroid requirements, Steroiddependent, Steroiddependent asthmatics, Strem, Substantial reduction, Such treatment, Suitable agent, Term agents, Useage, Various terms.
Url:
DOI: 10.1016/S0140-6736(05)78455-5
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000436
- to stream Istex, to step Curation: 000436
- to stream Istex, to step Checkpoint: 001547
- to stream Main, to step Merge: 002785
- to stream Main, to step Curation: 002743
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Non-steroidal anti-inflammatory therapy for asthma</title><author><name sortKey="Kay, Ab" sort="Kay, Ab" uniqKey="Kay A" first="Ab" last="Kay">Ab Kay</name></author><author><name sortKey="Barnes, Nc" sort="Barnes, Nc" uniqKey="Barnes N" first="Nc" last="Barnes">Nc Barnes</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D2EE79A5FFD471EDB3E6250EEFEABEBAAF09E48E</idno><date when="1998" year="1998">1998</date><idno type="doi">10.1016/S0140-6736(05)78455-5</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-R915VBZB-2/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000436</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000436</idno><idno type="wicri:Area/Istex/Curation">000436</idno><idno type="wicri:Area/Istex/Checkpoint">001547</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001547</idno><idno type="wicri:doubleKey">0140-6736:1998:Kay A:non:steroidal:anti</idno><idno type="wicri:Area/Main/Merge">002785</idno><idno type="wicri:Area/Main/Curation">002743</idno><idno type="wicri:Area/Main/Exploration">002743</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Non-steroidal anti-inflammatory therapy for asthma</title><author><name sortKey="Kay, Ab" sort="Kay, Ab" uniqKey="Kay A" first="Ab" last="Kay">Ab Kay</name><affiliation wicri:level="3"><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><wicri:orgArea>Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College School of Medicine, London SW3 6LY, UK; and London Chest Hospital</wicri:orgArea></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College School of Medicine, London SW3 6LY</wicri:regionArea><wicri:noRegion>London SW3 6LY</wicri:noRegion></affiliation></author><author><name sortKey="Barnes, Nc" sort="Barnes, Nc" uniqKey="Barnes N" first="Nc" last="Barnes">Nc Barnes</name><affiliation wicri:level="3"><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><wicri:orgArea>Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College School of Medicine, London SW3 6LY, UK; and London Chest Hospital</wicri:orgArea></affiliation></author></analytic><monogr></monogr><series><title level="j">The Lancet</title><title level="j" type="abbrev">LANCET</title><idno type="ISSN">0140-6736</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1998">1998</date><biblScope unit="volume">351</biblScope><biblScope unit="issue">9103</biblScope><biblScope unit="page" from="672">672</biblScope></imprint><idno type="ISSN">0140-6736</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0140-6736</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Allergy</term><term>Analgesic</term><term>Antiinflammatory</term><term>Antiinflammatory effects</term><term>Antiinflammatory therapy</term><term>Arthur banner</term><term>Asthma</term><term>Asthmatic</term><term>Asthmatic patients</term><term>Banner states</term><term>Banner1</term><term>Beneficial effect</term><term>Brompton</term><term>Bronchial asthma</term><term>Capell</term><term>Capell centre</term><term>Chronic asthma</term><term>Clinical immunology</term><term>Correspondence commentary correspondence therapy</term><term>Corticosteroid</term><term>Crit</term><term>Crossover</term><term>Crossover study</term><term>Crossover trial</term><term>Current medication</term><term>Cyclosporin</term><term>Difficult asthmatics</term><term>Disease exacerbations</term><term>Diseasemodifying</term><term>Dmards</term><term>Doubleblind</term><term>February</term><term>Further multicentre studies</term><term>Gammaglobulin</term><term>Gunneberg</term><term>Hydroxychloroquine</term><term>Immunoglobulin</term><term>Immunoglobulin treatment</term><term>Immunology</term><term>Imperial college school</term><term>Important option</term><term>Important placebo effect</term><term>Individual patient</term><term>Intravenous</term><term>Intravenous immunoglobulin</term><term>Lancet</term><term>London chest hospital</term><term>Lung function</term><term>Lung institute</term><term>Madhok</term><term>Methotrexate</term><term>Methotrexate spares</term><term>Methotrexate trials</term><term>Multicentre</term><term>National heart</term><term>Nonsteroidal</term><term>Nonsteroidal drugs</term><term>Nsaid</term><term>Open studies</term><term>Oral corticosteroid doses</term><term>Oral corticosteroid therapy</term><term>Particular interest</term><term>Pathway</term><term>Pediatrics</term><term>Pharmacol</term><term>Placebo</term><term>Potential benefit</term><term>Prednisolone</term><term>Prednisolone dose</term><term>Prostaglandin</term><term>Prostaglandin synthesis</term><term>Pulm</term><term>Pulm pharmacol</term><term>Referenced</term><term>Referenced doubleblind</term><term>Respir</term><term>Respir crit care</term><term>Rheumatic diseases</term><term>Rheumatologist</term><term>Royal brompton hospital</term><term>Royal infirmary</term><term>Saards</term><term>Several trials</term><term>Severe asthma</term><term>Severe asthmatics</term><term>Steroid</term><term>Steroid reduction</term><term>Steroid requirements</term><term>Steroiddependent</term><term>Steroiddependent asthmatics</term><term>Strem</term><term>Substantial reduction</term><term>Such treatment</term><term>Suitable agent</term><term>Term agents</term><term>Useage</term><term>Various terms</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Kay, Ab" sort="Kay, Ab" uniqKey="Kay A" first="Ab" last="Kay">Ab Kay</name></region><name sortKey="Barnes, Nc" sort="Barnes, Nc" uniqKey="Barnes N" first="Nc" last="Barnes">Nc Barnes</name><name sortKey="Kay, Ab" sort="Kay, Ab" uniqKey="Kay A" first="Ab" last="Kay">Ab Kay</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002743 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002743 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D2EE79A5FFD471EDB3E6250EEFEABEBAAF09E48E
|texte= Non-steroidal anti-inflammatory therapy for asthma
}}
| This area was generated with Dilib version V0.6.33. |  |